AMETEK (AME) Earnings: Q3 2026 Results and Next Report Date

The quarter ended September 30, 2026 and AMETEK published the results on November 3, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. AMETEK reports EPS two ways: GAAP, under the accounting rules every US filer follows, and Adjusted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• AMETEK completed the acquisition of Indicor Instrumentation in August 2026 for $4,921.4 million in cash, net of cash acquired. Indicor has annual sales of about $1.1 billion, and its businesses were placed in both EIG and EMG.
• AMETEK's adjusted EPS adds back after-tax amortization of acquisition-related intangible assets and acquisition-related transaction and integration costs.

Source: AMETEK Q3 2026 results, November 3, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How AMETEK splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• AMETEK's Electronic Instruments revenue was $1.4 billion in Q3 2026, up 16% from $1.2 billion in Q3 2025, 65% of total revenue.
• AMETEK's Electromechanical revenue was $778 million in Q3 2026, up 20% from $646 million in Q3 2025, 35% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, AMETEK said:

“For 2026, we now expect overall sales to be up mid-teens on a percentage basis versus 2025.”

“Adjusted earnings per diluted share are now expected to be in the range of $8.53 to $8.57, up approximately 15% from our full year 2025 results.”

“For the fourth quarter of 2026, overall sales are expected to be up in the low 20% range versus the fourth quarter of 2025.”

“Adjusted earnings in the quarter are expected to be in the range of $2.26 to $2.30 per share, up 12% to 14% compared to the fourth quarter of 2025”

Source: AMETEK Q3 2026 release, Nov 3, 2026.

This is the company's own guidance as of Nov 3, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the AME forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

Net sales and GAAP diluted EPS, each as first reported in that quarter's release. AMETEK reports in thousands; figures here are in millions.

AMETEK's next report is expected around February 2, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 3, 2026

AMETEK sells through two operating groups. Electronic Instruments (EIG) makes advanced instruments for the process, power and industrial, and aerospace markets. Electromechanical (EMG) supplies precision motion control, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects. (AMETEK Form 10-K, 2025, Feb 17, 2026)

AMETEK's Q3 2026 net sales were a record $2,220.3 million, up 17.3% from $1,892.6 million. Organic sales rose 10% and acquisitions added 7%. EIG sales were $1,442.3 million, up 15.7% on 9% organic growth, and EMG sales were $778.0 million, up 20.4% on 13% organic growth, each with a 7% contribution from acquisitions. (AMETEK Form 10-Q, Q3 2026, Nov 3, 2026)

The largest acquisition was Indicor Instrumentation, completed in August 2026. Indicor has annual sales of about $1.1 billion and a total purchase price of $5,154.1 million. AMETEK spent $5,345.8 million in cash, net of cash acquired, on LKC Technologies (January), First Aviation Services (May) and Indicor in the first nine months of 2026. (AMETEK Form 10-Q, Q3 2026, Nov 3, 2026)

International sales were $1,060.9 million, or 47.8% of net sales, up 17.1%, which AMETEK attributed mainly to higher demand in Asia and recent acquisitions. In 2025, 42% of EMG's net sales were to customers outside the United States. (AMETEK Form 10-Q, Q3 2026, Nov 3, 2026; AMETEK Form 10-K, 2025, Feb 17, 2026)

Orders ran ahead of sales. Q3 2026 orders were a record $2,650.6 million, up 34.7%, with 17% organic growth and 18% from acquisitions, and the backlog of unfilled orders reached a record $4,540.5 million at September 30, 2026, against $3,581.5 million at December 31, 2025. (AMETEK Form 10-Q, Q3 2026, Nov 3, 2026)

AMETEK's GAAP diluted EPS was $1.85 in Q3 2026 and adjusted EPS was $2.21, up 17% from $1.89. The $0.36 gap is mostly pretax amortization of acquisition-related intangible assets ($0.35, less a $0.09 tax benefit) plus acquisition-related costs ($0.12, less a $0.03 tax benefit). Those costs included $9.8 million of Indicor integration costs in cost of sales and $18.1 million in other expense, primarily representation and warranty insurance. (AMETEK Q3 2026 release (Form 8-K, Exhibit 99.1), Nov 3, 2026; AMETEK Form 10-Q, Q3 2026, Nov 3, 2026)

Paying for Indicor raised AMETEK's borrowing costs. Interest expense rose 76.9% to $39.8 million because of the revolving credit and term loan borrowings tied to the deal, and AMETEK borrowed $4.0 billion in three term loan tranches in the quarter. Long-term debt, net was $6,029.6 million at September 30, 2026, against $1,074.3 million at December 31, 2025. (AMETEK Form 10-Q, Q3 2026, Nov 3, 2026; AMETEK Q3 2026 release (Form 8-K, Exhibit 99.1), Nov 3, 2026)

The effective tax rate was 18.3%, against 17.1% a year earlier, when the remeasurement of deferred tax liabilities after Germany cut its corporate tax rate lowered the rate. Diluted shares fell to 230,040 thousand from 231,670 thousand. AMETEK spent $28.2 million repurchasing stock in the first nine months of 2026, against $163.6 million a year earlier. (AMETEK Form 10-Q, Q3 2026, Nov 3, 2026; AMETEK Q3 2026 release (Form 8-K, Exhibit 99.1), Nov 3, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

AMETEK gives a numeric outlook in its release. With Q3 2026 results it raised its 2026 adjusted EPS range to $8.53 to $8.57, from $8.20 to $8.30, citing the quarter, the fourth-quarter outlook and the expected contribution from Indicor. It expects 2026 sales up mid-teens on a percentage basis. (AMETEK Q3 2026 release (Form 8-K, Exhibit 99.1), Nov 3, 2026)

For Q4 2026, AMETEK expects sales up in the low 20% range and adjusted EPS of $2.26 to $2.30, up 12% to 14% from Q4 2025. The matching GAAP range is $1.93 to $1.97, with $0.44 of pretax amortization of acquisition-related intangibles added back. (AMETEK Q3 2026 release (Form 8-K, Exhibit 99.1), Nov 3, 2026)

A consensus figure is the average of the models published by the analysts who cover AMETEK, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones AMETEK's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning AME is on is AME a buy or a sell?, what analysts expect next is on the AME forecast, and what the company does is on the AMETEK (AME) stock page.

Every number on this page can be traced to a document AMETEK published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.